Immix Biopharma Inc (IMMX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $657.09M
Last updated: Nov 17, 2026 at 11:05 AM ET
Immix Biopharma Inc (IMMX) Earnings: Report Dates and Results
Immix Biopharma (IMMX) is expected to report earnings on Mar 23, 2027. In the quarter ended Sep 30, 2026, Immix Biopharma reported EPS of -$0.19, below the -$0.18 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IMMX has an expected report date of Mar 23, 2027.
Earnings History
Of the 17 quarters below that had an estimate, IMMX beat 4, missed 10 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 86.67% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.19 | -$0.18 | -$0.21 - -$0.17 | -5.56% | Miss | N/A | 7 | 1 up, 0 down | Nov 12, 2026 |
| Jun 30, 2026 | -$0.18 | -$0.17 | -$0.22 - -$0.15 | -5.88% | Miss | N/A | 7 | 3 up, 1 down | Aug 7, 2026 |
| Mar 31, 2026 | -$0.18 | -$0.21 | -$0.25 - -$0.17 | +14.29% | Beat | N/A | 4 | 0 up, 1 down | May 7, 2026 |
| Dec 31, 2025 | -$0.28 | -$0.15 | -$0.21 - -$0.13 | -86.67% | Miss | N/A | 3 | 1 up, 0 down | Mar 25, 2026 |
| Sep 30, 2025 | -$0.24 | -$0.19 | -$0.19 - -$0.19 | -26.32% | Miss | N/A | 1 | 0 up, 1 down | Nov 7, 2025 |
| Jun 30, 2025 | -$0.22 | -$0.16 | -$0.16 - -$0.16 | -37.50% | Miss | N/A | 1 | 1 up, 0 down | Aug 8, 2025 |
| Mar 31, 2025 | -$0.15 | -$0.23 | -$0.23 - -$0.23 | +34.78% | Beat | N/A | 1 | 0 up, 1 down | May 8, 2025 |
| Dec 31, 2024 | -$0.25 | -$0.25 | -$0.25 - -$0.25 | 0.00% | In line | N/A | 1 | 0 up, 1 down | Mar 24, 2025 |
| Sep 30, 2024 | -$0.24 | -$0.16 | -$0.16 - -$0.16 | -50.00% | Miss | N/A | 1 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$0.15 | -$0.21 | -$0.21 - -$0.21 | +28.57% | Beat | N/A | 1 | 0 up, 0 down | Aug 12, 2024 |
| Mar 31, 2024 | -$0.22 | -$0.23 | N/A | +4.35% | Beat | N/A | N/A | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.23 | -$0.23 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Mar 29, 2024 |
| Sep 30, 2023 | -$0.23 | -$0.23 | -$0.23 - -$0.23 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Nov 9, 2023 |
| Jun 30, 2023 | -$0.24 | -$0.17 | -$0.17 - -$0.17 | -41.18% | Miss | N/A | 1 | 0 up, 0 down | Aug 11, 2023 |
| Mar 31, 2023 | -$0.18 | -$0.14 | -$0.14 - -$0.14 | -28.57% | Miss | N/A | 1 | 0 up, 0 down | May 12, 2023 |
| Dec 31, 2022 | -$0.27 | -$0.22 | N/A | -22.73% | Miss | N/A | 1 | 0 up, 1 down | Mar 27, 2023 |
| Sep 30, 2022 | -$0.11 | -$0.11 | N/A | -0.18% | Miss | N/A | N/A | N/A | Nov 9, 2022 |
| Jun 30, 2022 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2022 |
| Mar 31, 2022 | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2022 |
| Dec 31, 2021 | -$3.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 28, 2022 |
| Sep 30, 2021 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 17, 2021 |
| Jun 30, 2021 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 17, 2021 |
| Mar 31, 2021 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2021 |
| Dec 31, 2020 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 |
| Jun 30, 2020 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 |
| Mar 31, 2020 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2020 |
| Dec 31, 2019 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.89, after -$0.86 the year before. It was -$0.04 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.89 | N/A |
| Dec 31, 2024 | -$0.86 | N/A |
| Dec 31, 2023 | -$0.88 | N/A |
| Dec 31, 2022 | -$0.59 | N/A |
| Dec 31, 2021 | -$3.52 | N/A |
| Dec 31, 2020 | -$0.26 | N/A |
| Dec 31, 2019 | -$0.04 | N/A |
Frequently Asked Questions About IMMX
When is Immix Biopharma's next earnings date?
Immix Biopharma's next earnings report is expected for Mar 23, 2027.
Did IMMX beat earnings estimates last quarter?
No. Immix Biopharma reported EPS of -$0.19 for the quarter ended Sep 30, 2026, below the -$0.18 estimate by 5.56%.
What EPS do analysts expect from IMMX next quarter?
The consensus EPS estimate for Immix Biopharma for the quarter ending Dec 31, 2026 is -$0.21 from 9 analysts, with estimates from -$0.25 to -$0.18.
How often does IMMX beat earnings estimates?
Immix Biopharma beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -14.11%.
IMMX pages: Overview, Earnings, Forecast, Financials, Competitors